135 related articles for article (PubMed ID: 21586699)
1. Pharmacological inhibition of Kv1.3 fails to modulate insulin sensitivity in diabetic mice or human insulin-sensitive tissues.
Straub SV; Perez SM; Tan B; Coughlan KA; Trebino CE; Cosgrove P; Buxton JM; Kreeger JM; Jackson VM
Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E380-90. PubMed ID: 21586699
[TBL] [Abstract][Full Text] [Related]
2. Voltage-gated potassium channel Kv1.3 regulates GLUT4 trafficking to the plasma membrane via a Ca2+-dependent mechanism.
Li Y; Wang P; Xu J; Desir GV
Am J Physiol Cell Physiol; 2006 Feb; 290(2):C345-51. PubMed ID: 16403947
[TBL] [Abstract][Full Text] [Related]
3. The Kv1.3 channel blocker Vm24 enhances muscle glucose transporter 4 mobilization but does not reduce body-weight gain in diet-induced obese male rats.
Jaimes-Hoy L; Gurrola GB; Cisneros M; Joseph-Bravo P; Possani LD; Charli JL
Life Sci; 2017 Jul; 181():23-30. PubMed ID: 28549558
[TBL] [Abstract][Full Text] [Related]
4. The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity.
Xu J; Wang P; Li Y; Li G; Kaczmarek LK; Wu Y; Koni PA; Flavell RA; Desir GV
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3112-7. PubMed ID: 14981264
[TBL] [Abstract][Full Text] [Related]
5. Margatoxin-bound quantum dots as a novel inhibitor of the voltage-gated ion channel Kv1.3.
Schwartz AB; Kapur A; Wang W; Huang Z; Fardone E; Palui G; Mattoussi H; Fadool DA
J Neurochem; 2017 Feb; 140(3):404-420. PubMed ID: 27861889
[TBL] [Abstract][Full Text] [Related]
6. Margatoxin binds to a homomultimer of K(V)1.3 channels in Jurkat cells. Comparison with K(V)1.3 expressed in CHO cells.
Helms LM; Felix JP; Bugianesi RM; Garcia ML; Stevens S; Leonard RJ; Knaus HG; Koch R; Wanner SG; Kaczorowski GJ; Slaughter RS
Biochemistry; 1997 Mar; 36(12):3737-44. PubMed ID: 9132027
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of glucose uptake in murine soleus muscle and adipocytes by 5-(4-phenoxybutoxy)psoralen (PAP-1) may be mediated by Kv1.5 rather than Kv1.3.
Ngala RA; Zaibi MS; Langlands K; Stocker CJ; Arch JR; Cawthorne MA
PeerJ; 2014; 2():e614. PubMed ID: 25320682
[TBL] [Abstract][Full Text] [Related]
8. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
[TBL] [Abstract][Full Text] [Related]
9. A type IV P-type ATPase affects insulin-mediated glucose uptake in adipose tissue and skeletal muscle in mice.
Dhar MS; Yuan JS; Elliott SB; Sommardahl C
J Nutr Biochem; 2006 Dec; 17(12):811-20. PubMed ID: 16517145
[TBL] [Abstract][Full Text] [Related]
10. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
11. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice.
Chen WY; Chen CJ; Liu CH; Mao FC
Diabetes Obes Metab; 2009 Apr; 11(4):293-303. PubMed ID: 18721257
[TBL] [Abstract][Full Text] [Related]
12. ATP-sensitive potassium channels participate in glucose uptake in skeletal muscle and adipose tissue.
Miki T; Minami K; Zhang L; Morita M; Gonoi T; Shiuchi T; Minokoshi Y; Renaud JM; Seino S
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1178-84. PubMed ID: 12388128
[TBL] [Abstract][Full Text] [Related]
13. Olfactory bulb-targeted quantum dot (QD) bioconjugate and Kv1.3 blocking peptide improve metabolic health in obese male mice.
Schwartz AB; Kapur A; Huang Z; Anangi R; Spear JM; Stagg S; Fardone E; Dekan Z; Rosenberg JT; Grant SC; King GF; Mattoussi H; Fadool DA
J Neurochem; 2021 Jun; 157(6):1876-1896. PubMed ID: 32978815
[TBL] [Abstract][Full Text] [Related]
14. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats.
Park SY; Choi GH; Choi HI; Ryu J; Jung CY; Lee W
Arch Biochem Biophys; 2005 Apr; 436(2):276-84. PubMed ID: 15797240
[TBL] [Abstract][Full Text] [Related]
15. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
16. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.
Dray C; Debard C; Jager J; Disse E; Daviaud D; Martin P; Attané C; Wanecq E; Guigné C; Bost F; Tanti JF; Laville M; Vidal H; Valet P; Castan-Laurell I
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1161-9. PubMed ID: 20233941
[TBL] [Abstract][Full Text] [Related]
17. Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle.
Hamilton DL; Beall C; Jeromson S; Chevtzoff C; Cuthbertson DJ; Ashford ML
J Physiol Sci; 2014 Jan; 64(1):13-20. PubMed ID: 24043354
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels.
Toldi G; Vásárhelyi B; Kaposi A; Mészáros G; Pánczél P; Hosszufalusi N; Tulassay T; Treszl A
Immunol Lett; 2010 Sep; 133(1):35-41. PubMed ID: 20603149
[TBL] [Abstract][Full Text] [Related]
19. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
20. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
Rodrigues AR; Arantes EC; Monje F; Stühmer W; Varanda WA
Br J Pharmacol; 2003 Jul; 139(6):1180-6. PubMed ID: 12871837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
